LUNDBECK LLC for LUNDBECK LLC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Manufacturing MAN
Health care issues, including importation of pharmaceutical products, comparative effectiveness research, strengthening the FDA, and reauthorization of the Orphan Drug Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J EGING New | Vice President, Government Affairs |
Government Issues GOV
Health care issues, including importation of pharmaceutical products, comparative effectiveness research, strengthening the FDA, and reauthorization of the Orphan Drug Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J EGING New | Vice President, Government Affairs |
Health Issues HCR
Health care issues, including importation of pharmaceutical products, comparative effectiveness research, strengthening the FDA, and reauthorization of the Orphan Drug Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL J EGING New | Vice President, Government Affairs |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| H. LUNDBECK A/S | Denmark | Denmark | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.